glp-1 drugs zepbound As Insurers Struggle With Drug Costs, Some Seek To Wean Patients Off Is Zepbound a Semaglutide GLP-1?

doi: 10.1016/S0196-9781(00)00287-4 [DOI] [PubMed] [Google Scholar] 47.Tahara N, Tahara A, Honda A, et al

Dry mouth and bad breath (known as Ozempic mouth) have resulted in a 20-percentage-point and a 24-percentage-point climb in in mouthwash and chewing gum confectionery spend, respectively, among GLP-1 user households compared to non-user households

Heres what the research actually says about the most-studied options

Thus, although much research is focused on defining the direct intrakidney effects of GLP-1 receptor agonists, it is possible that some of the benefits occur indirectly, as a result of GLP-1 receptor agonists ability to improve kidney risk factors, as well as via extrarenal systemic effects of these agents that are not yet fully defined, such as attenuation of low-grade systemic inflammation

Step therapy before approval

The participants were then regularly assessed by the research team for 52 week